News
IDE Approval Received from the FDA for the SWIFT multi-centre, open, randomized, controlled, parallel-group, blind-assessed trial
6 June 2022
/ News
IDE approval was received in April 2022 from the FDA for the SWIFT multi-centre, open, randomized, controlled, parallel-group, blind-assessed trial.
Scottish health tech innovator hits 100,000 treatments in UK
31 May 2022
/ News
The Emblation team are proud to have launched in Europe’s biggest healthcare market, after striking a partnership deal with a leading German medical device company.
German deal is milestone for Scots microwave health pioneer
27 April 2022
/ News
The Emblation team are proud to have launched in Europe’s biggest healthcare market, after striking a partnership deal with a leading German medical device company.
Microwave health tech firm uses war chest to conquer Europe
30 March 2022
/ News
Our burgeoning health tech firm is tapping into an eight-figure investment war chest to deliver rapid European growth.
Emblation shortlisted for two Ceed Annual Industry Awards
22 February 2022
/ News
Emblation is delighted to announce we have been shortlisted for two Ceed awards, Innovation and Internationalisation.
Microwaves: a new treatment for plantar warts
9 October 2021
/ News
Podiatry Management magazine has published a new paper describing microwave treatments as a painless, efficient new treatment for plantar warts
Emblation Shortlisted For Institution of Engineering and Technology Innovation Awards
16 October 2020
/ News
Emblation has been shortlisted for The Institution of Engineering and Technology E&T Innovation Awards for Model-Based Engineering.
